Experimental Gingivitis in Patients With Altered Passive Eruption
1 other identifier
interventional
18
1 country
1
Brief Summary
Altered passive eruption (APE) is an anatomical condition that is frequently diagnosed in periodontal clinical practice, especially for the ever-increasing demand of patients for the aesthetic improvement of their smile. In addition to its aesthetic value, however, altered passive eruption could also affect gingival and periodontal health. In fact, in the case of plaque accumulation, the altered passive eruption (APE) is likely to be a predisposing factor for a more rapid progression of gingivitis with higher inflammation indexes (Angulated Bleeding Score - AngBs and Modified Gingival Index - mGI). Notwithstanding, even if gingivitis in patients with altered passive eruption is developed much more rapidly, thorough home oral hygiene and plaque control conduces to complete clinical recovery. Further studies with a large number of patients are required to confirm the correlation between altered passive eruption and periodontal diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 21, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 19, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 19, 2017
CompletedFirst Submitted
Initial submission to the registry
April 27, 2018
CompletedFirst Posted
Study publicly available on registry
May 11, 2018
CompletedJune 6, 2019
June 1, 2019
5 months
April 27, 2018
June 5, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Change of Angulated bleeding score (AngBS)
Angulated bleeding score (AngBS) was introduced by Trombelli et al, which is a modification of the angulated bleeding index as reported by van der Weijden. After lightly drying the gingiva with compressed air, a periodontal probe (PCP 15 University of North Carolina(UNC), Hu Friedy, Chicago, Illinois, USA) was held at an angle of approximately 60° to the longitudinal axis of the tooth and in contact with the sulcular gingival tissues. Angulated bleeding score (AngBS) was scored as: 0: no bleeding; 1. bleeding upon probe stimulation; 2. spontaneous bleeding.
Change of the value was assessed at T0, at day seven, fourteen, twenty-one, twenty-eight , thirty-five and at day forty-two
Change of Gingival index (MGI)
Gingival index (MGI) according to Silness \& Loe, but without probing component, due to not disturb plaque accumulation, was registered as: 1. \- Normal gingiva; 2. \- Mild inflammation - slight change in color and slight edema 3. \- Moderate inflammation - redness, edema and glazing, 4. \- Severe inflammation - marked redness and edema, ulceration with tendency to spontaneous bleeding.
Change of the value was assessed at T0, at day seven, fourteen, twenty-one, twenty-eight , thirty-five and at day forty-two
Secondary Outcomes (3)
Plaque index (PLI)
Value was assessed at T0, at day seven, fourteen, twenty-one, twenty-eight , thirty-five and at day forty-two
Quigley Hein Plaque Index (QH)
Value was assessed at T0, at day seven, fourteen, twenty-one, twenty-eight , thirty-five and at day forty-two
Gingival crevicular fluid volume (GCF)
Value was assessed at T0, at day seven, fourteen, twenty-one, twenty-eight , thirty-five and at day forty-two
Study Arms (2)
Patients with altered passive eruption - APE
EXPERIMENTAL3 teeth of the patients with altered passive eruption that will undergo to experimental gingivitis
Patients with normal gingival anatomy - Non APE
ACTIVE COMPARATOR3 teeth of the patients with normal gingival anatomy that will undergo to experimental gingivitis
Interventions
Individual cast models were prepared on alginate impressions. A 2-mm thick film of technical wax was set on the supra gingival area at buccal and proximal surfaces of study teeth on test quadrant. The stent were delivered at day 0. Subjects were instructed to wear the stent prior to the oral hygiene session throughout the experimental gingivitis period to prevent plaque removal during brushing of the remaining dentition. On Day 42 (T6): After recording of clinical parameters, oral hygiene instruction and an additional session of supragingival scaling, as needed, and polishing were given.
Eligibility Criteria
You may qualify if:
- age ≥ 18 years
- probing depth ≤ 3 mm
You may not qualify if:
- Smoking
- Periodontitis
- Systemic diseases
- Immunosuppressed or immunocompromised patients
- Use of medications affecting periodontal status
- Uncontrolled diabetes
- Pregnancy or lactation
- Addiction to alcohol or drugs
- Psychiatric problems
- Presence of any restorations on the examined quadrant
- Presence of periapical and endo-perio lesions
- Teeth with malposition and alteration in crown morphology
- Patients with an acute infection (abscess) in the site intended for treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rustam Aghazadalead
Study Sites (1)
Dipartimento di Scienze Odontostomatologiche e Maxillo Facciali
Roma, RM, 00161, Italy
Study Officials
- STUDY CHAIR
Andrea Pilloni, MD, DDS, MSc
University of Roma La Sapienza
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 27, 2018
First Posted
May 11, 2018
Study Start
February 21, 2017
Primary Completion
July 19, 2017
Study Completion
July 19, 2017
Last Updated
June 6, 2019
Record last verified: 2019-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF